congenital heart disease
Conditions
Interventions
Group RA:Remiazolam and alfentanyl were used during induction.
Group PS:Propofol and sufentanil were used during induction.
Sponsors
Shanghai Children's Medical Center
Eligibility
Sex/Gender
All
Age
2 Years to 6 Years
Inclusion criteria
Inclusion criteria: children aged from 2 to 6 years old, regardless of gender; children with congenital heart disease who need elective congenital heart disease correction (mainly left-to-right shunt); American College of Anesthesiologists (American Society of Anesthesiologists,ASA) grade II~IV; the guardian of the child voluntarily signed the informed consent form;
Exclusion criteria
Exclusion criteria: emergency surgery; history of allergy to experimental drugs; severe organic diseases before operation; vasoactive drugs used before operation; children and their guardians refused to participate in the study
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Choking reflex;Disappearance time of eyelash reflex;success rate of induction;Injection pain; | — |
Primary
| Measure | Time frame |
|---|---|
| Incidence of hypotension; | — |
Countries
China
Contacts
Public ContactZheng Jijian
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed